应用肝脏影像报告和数据系统2018版辅助特征在钆塞酸增强MRI上将LR-4升级为LR-5
本研究回顾性纳入280例高危患者共366个观察灶(含281个HCC),在钆塞酸增强MRI上评估LI-RADS v2018主要特征和辅助特征。逻辑回归筛选出4个独立显著辅助特征,将其与仅凭主要特征判定的LR-4组合形成升级版LR-5标准,敏感度较标准LR-5提高(69.4-76.9% vs 66.2%),特异度无显著差异。
要点
- 独立显著辅助特征为轻-中度T2高信号、肝胆期低信号、无强化「包膜」和镶嵌结构。
- 仅凭主要特征判为LR-4的观察灶,联合上述任一辅助特征升级为LR-5可提高诊断敏感度。
- 升级版LR-5标准特异度与标准LR-5无显著差异。
核心结论
- 独立显著的辅助特征可用于将仅凭主要特征判定的LR-4升级为LR-5,在钆塞酸增强MRI上提高HCC诊断敏感度而不损害特异度。
研究设计与样本
- 回顾性研究,纳入280例HCC高危患者共366个观察灶(含281个HCC),均接受钆塞酸增强MRI检查,检查时间为2015年至2017年。
- 由2名阅片者评估每个观察灶的主要特征和辅助特征并赋予LI-RADS分类,通过逻辑回归分析识别独立显著的辅助特征。
- 将独立显著辅助特征与仅凭主要特征判定的LR-4组合,构建升级版LR-5标准,采用McNemar检验比较各诊断标准的敏感度和特异度。
关键影像表现/征象
- 独立显著的偏向恶性(一般)辅助特征为轻-中度T2高信号和肝胆期低信号。
- 独立显著的偏向HCC(特定)辅助特征为无强化「包膜」和镶嵌结构。
诊断标准与关键数值
- 标准LR-5(仅主要特征)诊断HCC的敏感度为66.2%,特异度为96.5%。
- 升级版LR-5标准(仅主要特征判定的LR-4联合上述任一辅助特征)敏感度为69.4-76.9%,均显著高于标准LR-5(所有p≤0.004)。
- 升级版LR-5标准特异度为95.3-96.5%,与标准LR-5的96.5%相比无显著差异(所有p>0.999)。
临床应用与阅片要点
- 对仅凭主要特征判为LR-4的观察灶,可评估是否存在轻-中度T2高信号、肝胆期低信号、无强化「包膜」或镶嵌结构,以考虑升级为LR-5。
- 升级版LR-5标准在保持特异度的同时提高敏感度,有助于非侵入性诊断HCC。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The current LR-5 criteria of Liver Imaging Reporting and Data System (LI-RADS) determined by only major features provide high specificity, but unsatisfactorily low sensitivity for the noninvasive diagnosis of hepatocellular carcinoma (HCC). This study aimed to identify significant ancillary features (AFs) in LI-RADS version 2018 and develop the upgraded LR-5 criteria to improve diagnostic performance on gadoxetic acid-enhanced magnetic resonance imaging (MRI).
METHODS: This retrospective study included 280 patients (366 observations including 281 HCCs) at high-risk for HCC who underwent gadoxetic acid-enhanced MRI between 2015 and 2017. Two readers evaluated major features and AFs for each observation and assigned a LI-RADS category. Independently significant AFs were identified through logistic regression analysis. Upgraded LR-5 criteria were developed by combining independently significant AFs with LR-4 assigned by major features alone. Sensitivities and specificities of the diagnostic criteria were compared using McNemar's test.
RESULTS: Two of the AFs favoring malignancy in general (mild-moderate T2 hyperintensity and hepatobiliary phase hypointensity) and two of the AFs favoring HCC in particular (nonenhancing "capsule" and mosaic architecture) were independently significant features for diagnosing HCC. By using the upgraded LR-5 criteria (LR-4 by major features alone + each aforementioned AF), sensitivities were significantly increased (69.4-76.9%) compared with the standard LR-5 (66.2%; all, p ≤ 0.004), whereas specificities (95.3-96.5%) were not significantly different (96.5%; all, p > 0.999).
CONCLUSIONS: Independently significant AFs may be used to upgrade from LR-4 to LR-5 to improve sensitivity without impairing specificity on gadoxetic acid-enhanced MRI.
KEY POINTS: • Independently significant AFs for HCC on gadoxetic acid-enhanced MRI were mild-moderate T2 hyperintensity, hepatobiliary phase hypointensity, nonenhancing "capsule," and mosaic architecture. • When LR-4 criteria by major features alone in combination with significant AFs were upgraded to LR-5, sensitivities were higher than the standard LR-5, without impairing specificity. • Independently significant ancillary features in Liver Imaging Reporting and Data System version 2018 may be used to upgrade from LR-4 to LR-5 to improve sensitivity without impairing specificity on gadoxetic acid-enhanced MRI.
引用
- Lee S, Kim SS, Bae H, et al. Application of Liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid-enhanced MRI. Eur Radiol. 2020. PMID: 32809162. doi:10.1007/s00330-020-07146-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。